Key Financial Data Of Group

ZERIA PHARMCEUTICAL CO., LTD. - Filing #7323356

Concept As at
2024-03-31
As at
2024-03-31
As at
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2024-03-31
As at
2024-03-31
As at
2024-03-31
As at
2024-03-31
As at
2024-03-31
2022-04-01 to
2023-03-31
As at
2023-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
As at
2021-03-31
2019-04-01 to
2020-03-31
As at
2020-03-31
2019-04-01 to
2020-03-31
As at
2020-03-31
Key financial data of group
Business results of group
Net sales
34,017,192,000 JPY
75,725,075,000 JPY
32,960,174,000 JPY
68,383,227,000 JPY
31,956,515,000 JPY
59,532,829,000 JPY
31,570,550,000 JPY
52,757,184,000 JPY
40,545,969,000 JPY
60,426,743,000 JPY
Ordinary profit (loss)
2,686,502,000 JPY
8,513,028,000 JPY
2,738,392,000 JPY
7,579,449,000 JPY
1,594,058,000 JPY
5,935,646,000 JPY
1,088,929,000 JPY
3,208,652,000 JPY
2,880,575,000 JPY
3,879,343,000 JPY
Profit (loss) attributable to owners of parent
7,731,262,000 JPY
6,195,865,000 JPY
3,961,184,000 JPY
3,143,125,000 JPY
2,925,375,000 JPY
Comprehensive income
16,089,850,000 JPY
12,857,913,000 JPY
2,992,868,000 JPY
6,250,212,000 JPY
-1,471,021,000 JPY
Net assets
79,828,792,000 JPY
40,035,077,000 JPY
38,023,049,000 JPY
65,680,710,000 JPY
55,092,474,000 JPY
38,252,193,000 JPY
56,152,673,000 JPY
41,329,422,000 JPY
52,678,846,000 JPY
42,234,057,000 JPY
Total assets
150,533,593,000 JPY
92,940,742,000 JPY
92,091,084,000 JPY
135,034,536,000 JPY
124,282,333,000 JPY
94,903,838,000 JPY
121,860,440,000 JPY
95,027,702,000 JPY
104,155,863,000 JPY
83,055,102,000 JPY
Net assets per share
1,806.33
908.24
862.59
1,484.79
1,236.09
861.34
1,225.09
904.39
1,134.30
912.32
Basic earnings (loss) per share
37.12
175.39
48.85
140.26
30.85
87.76
27.65
68.22
40.46
62.62
Diluted earnings per share
Equity-to-asset ratio
0.529 xbrli:pure
0.431 xbrli:pure
0.413 xbrli:pure
0.485 xbrli:pure
0.442 xbrli:pure
0.403 xbrli:pure
0.459 xbrli:pure
0.435 xbrli:pure
0.504 xbrli:pure
0.509 xbrli:pure
Rate of return on equity
0.042 xbrli:pure
0.107 xbrli:pure
0.057 xbrli:pure
0.103 xbrli:pure
0.035 xbrli:pure
0.071 xbrli:pure
0.030 xbrli:pure
0.058 xbrli:pure
0.043 xbrli:pure
0.052 xbrli:pure
Price-earnings ratio
57.4 xbrli:pure
12.2 xbrli:pure
46.0 xbrli:pure
16.0 xbrli:pure
61.7 xbrli:pure
21.7 xbrli:pure
76.1 xbrli:pure
30.8 xbrli:pure
51.6 xbrli:pure
33.3 xbrli:pure
Net cash provided by (used in) operating activities
12,183,609,000 JPY
13,157,415,000 JPY
8,950,932,000 JPY
6,894,290,000 JPY
7,251,345,000 JPY
Net cash provided by (used in) investing activities
-3,952,373,000 JPY
-2,574,517,000 JPY
-2,892,814,000 JPY
-17,460,812,000 JPY
-405,119,000 JPY
Net cash provided by (used in) financing activities
-8,124,090,000 JPY
-7,415,068,000 JPY
-4,841,212,000 JPY
11,185,277,000 JPY
-5,877,764,000 JPY
Cash and cash equivalents
18,604,144,000 JPY
16,094,078,000 JPY
11,579,282,000 JPY
9,668,938,000 JPY
8,880,252,000 JPY
Number of employees
335 xbrli:pure
304 xbrli:pure
288 xbrli:pure
184 xbrli:pure
7 xbrli:pure
639 xbrli:pure
1,777 xbrli:pure
xbrli:pure
753 xbrli:pure
729 xbrli:pure
1,482 xbrli:pure
823 xbrli:pure
840 xbrli:pure
1,729 xbrli:pure
1,737 xbrli:pure
859 xbrli:pure
1,690 xbrli:pure
872 xbrli:pure
1,667 xbrli:pure
919 xbrli:pure
Average number of temporary employees
92 xbrli:pure
49 xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
141 xbrli:pure
150 xbrli:pure
xbrli:pure
101 xbrli:pure
49 xbrli:pure
150 xbrli:pure
141 xbrli:pure
135 xbrli:pure
143 xbrli:pure
135 xbrli:pure
125 xbrli:pure
136 xbrli:pure
125 xbrli:pure
134 xbrli:pure
126 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.